Stjepanovic MI et al. |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report. |
2016 |
Infez Med |
pmid:28011973
|
Abuhammour A et al. |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients. |
2016 |
Arab J Gastroenterol |
pmid:27665525
|
Matsumoto H et al. |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. |
2016 |
Dig. Dis. Sci. |
pmid:27659671
|
Gisbert JP |
Helicobacter pylori-related diseases. |
2016 |
Gastroenterol Hepatol |
pmid:27888863
|
Rossi A et al. |
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations. |
2016 |
Drug Dev Ind Pharm |
pmid:26065531
|
Harada T et al. |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27489022
|
Bonfigli AR et al. |
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. |
2016 |
Nutr Metab Cardiovasc Dis |
pmid:27480449
|
Orrin E et al. |
Sporotrichoid Mycobacterium chelonae. |
2016 |
Australas. J. Dermatol. |
pmid:27469486
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Mitchell H and Katelaris P |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. |
2016 |
Med. J. Aust. |
pmid:27256648
|
Ullah S et al. |
Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. |
2016 |
Drug Deliv |
pmid:27247018
|
Kuo CH et al. |
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice. |
2016 |
Medicine (Baltimore) |
pmid:27227911
|
Sluch IM et al. |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection. |
2016 |
Cornea |
pmid:27227391
|
Matsumoto H et al. |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. |
2016 |
Helicobacter |
pmid:27061611
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Buchicchio A et al. |
Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography - high-resolution tandem mass spectrometry (FTICR MS-IRMPD). |
2016 |
Sci. Total Environ. |
pmid:27039063
|
Melia MT and Auwaerter PG |
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. |
2016 |
N. Engl. J. Med. |
pmid:27028918
|
Tepeš B et al. |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. |
2016 |
Eur J Gastroenterol Hepatol |
pmid:26862930
|
Lim SG et al. |
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use. |
2016 |
Dig Liver Dis |
pmid:26856963
|
Niv Y |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis. |
2016 |
Digestion |
pmid:26849820
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Qiu XH et al. |
Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells. |
2016 |
Acta Haematol. |
pmid:26505646
|
Ghaith D et al. |
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt. |
2016 |
J Chemother |
pmid:26358218
|
Li Y et al. |
Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection. |
2015 |
Drug Deliv |
pmid:24471983
|
Sobajima T et al. |
A Case of Pulmonary Actinomycosis Associated With Aspiration of Cedar Leaves. |
2015 |
J Bronchology Interv Pulmonol |
pmid:26165898
|
Gunjan S et al. |
Clarithromycin enhances the antimalarial efficacy of mefloquine via its increased bioavailability and disrupting P. falciparum apicoplast. |
2015 |
Life Sci. |
pmid:26164186
|
Tongtawee T et al. |
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial. |
2015 |
Asian Pac. J. Cancer Prev. |
pmid:26163609
|
Fujimura S et al. |
Antimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devices. |
2015 |
J. Infect. Chemother. |
pmid:26162777
|
Converse PJ et al. |
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. |
2015 |
PLoS Negl Trop Dis |
pmid:26042792
|
Klain V and Timmerman L |
Comment on The dangers of gastritis: a case of clarithromycin-associated brief psychotic episode. |
2015 |
J. Nerv. Ment. Dis. |
pmid:26034875
|
Prapitpaiboon H et al. |
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand. |
2015 |
Asian Pac. J. Cancer Prev. |
pmid:26028098
|
Nayyar E and Taimur S |
Sporotrichoid lesions: an age-old conundrum. |
2015 |
Am. J. Med. |
pmid:26021809
|
Harb AH et al. |
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26011564
|
Heo J et al. |
Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial. |
2015 |
J. Gastroenterol. Hepatol. |
pmid:25867608
|
Sugita S et al. |
EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells. |
2015 |
Biochem. Biophys. Res. Commun. |
pmid:25858318
|
Kesselheim AS et al. |
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population. |
2015 |
J Gen Intern Med |
pmid:25855479
|
Gianni C |
Treatment and prevention of paronychia using a new combination of topicals: report of 30 cases. |
2015 |
G Ital Dermatol Venereol |
pmid:25854670
|
Zhang S et al. |
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. |
2015 |
Cancer Lett. |
pmid:25853150
|
Iino Y et al. |
Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media. |
2015 |
Acta Otolaryngol. |
pmid:25649881
|
Streetman DS and Stout SM |
Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4? |
2015 |
CMAJ |
pmid:25646282
|
Ang TL et al. |
Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection. |
2015 |
J. Gastroenterol. Hepatol. |
pmid:25639278
|
Jiang F et al. |
The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes. |
2015 |
Psychopharmacology (Berl.) |
pmid:25510856
|
Kim H et al. |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. |
2015 |
Ann. Hematol. |
pmid:25501820
|
Keshavarz Azizi Raftar S et al. |
The Helicobacter pylori resistance rate to clarithromycin in Iran. |
2015 |
Microb. Drug Resist. |
pmid:25144338
|
Chan CC et al. |
Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia. |
2015 |
BMC Gastroenterol |
pmid:26635102
|
Hsu PI et al. |
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection. |
2015 |
Medicine (Baltimore) |
pmid:26632893
|
Buch T and Andersen SE |
[Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval]. |
2015 |
Ugeskr. Laeg. |
pmid:26471025
|
Kiesewetter B et al. |
Clarithromycin Leading to Complete Remission in the First-Line Treatment of Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma. |
2015 |
J. Clin. Oncol. |
pmid:24778391
|
Zhang W et al. |
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. |
2015 |
Gut |
pmid:26338726
|
Fasciana T et al. |
Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily. |
2015 |
J. Med. Microbiol. |
pmid:26338221
|